{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/6810f8439704d99f8410f9a2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Kate Sasser: How Lab-in-the-loop Turns Patient Data Into Patient Care","description":"<p>For years, Tempus operated in mystery—its website sparse on details while headlines announced massive funding and high-profile partnerships. The claim? AI-enabled solutions for personalized healthcare. Intrigued, I sought answers. In this episode, Kate Sasser, PhD, Chief Scientific Officer at Tempus, shared insights into how the company uses AI to analyze unstructured clinical data to develop patient-derived organoid models for therapeutic refinement. Most exciting is their vision of an interconnected “lab-in-a-loop” system—a cycle of real-world data, biological modeling, and AI analysis.</p><p><br></p><p>Produced and hosted by Jonathan D. Grinstein, PhD</p><p><br></p><p>Audio mixed and mastered by David Mosely</p><p><br></p><p>Brought to you by Inside Precision Medicine (SAGE Publishing)</p>","author_name":"Inside Precision Medicine"}